| 发明名称 |
BUTYROGENIC BACTERIA AS PROBIOTICS TO TREAT CLOSTRIDIUM DIFFICILE |
| 摘要 |
The subject invention pertains to the use of certain bacterial strains, particularly butyrogenic bacteria, for preparing a composition to treat and/or prevent Clostridium difficile infection. In particular, the invention relates to the use of butyrate-producing anaerobic fermenters of gut commensals in pharmaceutical or food compositions. |
| 申请公布号 |
US2016022745(A1) |
申请公布日期 |
2016.01.28 |
| 申请号 |
US201414773432 |
申请日期 |
2014.03.09 |
| 申请人 |
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. |
发明人 |
WANG Gary P. |
| 分类号 |
A61K35/741;C12Q1/68;A23L1/30;A61K35/744 |
主分类号 |
A61K35/741 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating Clostridium difficile infection (CDI) comprising the step of administering to a mammal an effective amount of a composition comprising at least one of the following strains of bacteria: Blautia, Pseudobutryrivibrio, Roseburia, Dorea, and Coprococcus. |
| 地址 |
Gainesville FL US |
